Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The lose of Brian and Wolf will hurt the value of this message board.

Did you miss this?

"The resolution included an agreement to provide a substantial increase in working capital for the MMP licensing program and patent infringement litigation from MMP licensing proceeds."

How does that fit with your comment that it's within the allowed capital range? If it were as you say, "in the range", why would a PR even be needed? The PR seems to clearly state that they've agreed to go SUBSTANTIALLY outside the previously allowed range.

Share
New Message
Please login to post a reply